Preferences for Attention-Deficit/Hyperactivity Disorder (ADHD) Non-Stimulant Treatment Characteristics Among Children and Adolescents With ADHD and Their Caregivers
**Background:** Understanding patient and caregiver preferences for treatment is important for optimizing treatment decisions. Non-stimulant therapies are an alternative treatment option to stimulant therapy for attention-deficit/hyperactivity disorder (ADHD). Guanfacine extended release (GXR) and a...
Saved in:
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Columbia Data Analytics, LLC
2016-10-01
|
Series: | Journal of Health Economics and Outcomes Research |
Online Access: | https://doi.org/10.36469/9842 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1823860351690604544 |
---|---|
author | Emuella Flood Kavita Gajria Vanja Sikirica Paul Hodgkins M. Haim Erder Frank Lopez Daniel Connor |
author_facet | Emuella Flood Kavita Gajria Vanja Sikirica Paul Hodgkins M. Haim Erder Frank Lopez Daniel Connor |
author_sort | Emuella Flood |
collection | DOAJ |
description | **Background:** Understanding patient and caregiver preferences for treatment is important for optimizing treatment decisions. Non-stimulant therapies are an alternative treatment option to stimulant therapy for attention-deficit/hyperactivity disorder (ADHD). Guanfacine extended release (GXR) and atomoxetine (ATX) are two non-stimulant medications approved in the United States for the treatment of ADHD.
**Objective:** To identify non-stimulant ADHD medication attributes important to caregivers/patients.
**Methods:** US caregivers of ADHD patients (6–17 years) and child/adolescent patients (10–17 years) completed an adaptive conjoint analysis survey. Respondents selected between hypothetical treatments with different attributes. Ordinary least-squares and hierarchical Bayes regression using Sawtooth Software were used to calculate utilities, importance ratings, and preferences.
**Results:** 483 caregivers (mean age: 41.9 years, standard deviation [SD]: 8.7; 75% female) and 211 children/adolescents (mean age: 14.5 years, SD: 2.2; 70% male) completed the survey. Based on importance ratings, the most influential attributes for both caregivers and children/adolescents were chance of somnolence, efficacy, and for caregivers, effect on oppositionality and black box warning. Most caregivers (95.3%) and children/adolescents (93.8%) preferred GXR over ATX. In several sensitivity analyses in which attribute levels varied, GXR remained the preferred medication with the exception of one scenario.
**Conclusions:** Children/adolescents and caregivers demonstrated in this study that they can clearly express their preferences for treatment attributes and treatment choices; in this case they preferred GXR to ATX. Patients and caregiver preferences could be useful inputs to the treatment selection decision-making process. |
format | Article |
id | doaj-art-7cf2505f2eab4ecdb556b525af8ad5eb |
institution | Kabale University |
issn | 2327-2236 |
language | English |
publishDate | 2016-10-01 |
publisher | Columbia Data Analytics, LLC |
record_format | Article |
series | Journal of Health Economics and Outcomes Research |
spelling | doaj-art-7cf2505f2eab4ecdb556b525af8ad5eb2025-02-10T16:12:42ZengColumbia Data Analytics, LLCJournal of Health Economics and Outcomes Research2327-22362016-10-0131Preferences for Attention-Deficit/Hyperactivity Disorder (ADHD) Non-Stimulant Treatment Characteristics Among Children and Adolescents With ADHD and Their CaregiversEmuella FloodKavita GajriaVanja SikiricaPaul HodgkinsM. Haim ErderFrank LopezDaniel Connor**Background:** Understanding patient and caregiver preferences for treatment is important for optimizing treatment decisions. Non-stimulant therapies are an alternative treatment option to stimulant therapy for attention-deficit/hyperactivity disorder (ADHD). Guanfacine extended release (GXR) and atomoxetine (ATX) are two non-stimulant medications approved in the United States for the treatment of ADHD. **Objective:** To identify non-stimulant ADHD medication attributes important to caregivers/patients. **Methods:** US caregivers of ADHD patients (6–17 years) and child/adolescent patients (10–17 years) completed an adaptive conjoint analysis survey. Respondents selected between hypothetical treatments with different attributes. Ordinary least-squares and hierarchical Bayes regression using Sawtooth Software were used to calculate utilities, importance ratings, and preferences. **Results:** 483 caregivers (mean age: 41.9 years, standard deviation [SD]: 8.7; 75% female) and 211 children/adolescents (mean age: 14.5 years, SD: 2.2; 70% male) completed the survey. Based on importance ratings, the most influential attributes for both caregivers and children/adolescents were chance of somnolence, efficacy, and for caregivers, effect on oppositionality and black box warning. Most caregivers (95.3%) and children/adolescents (93.8%) preferred GXR over ATX. In several sensitivity analyses in which attribute levels varied, GXR remained the preferred medication with the exception of one scenario. **Conclusions:** Children/adolescents and caregivers demonstrated in this study that they can clearly express their preferences for treatment attributes and treatment choices; in this case they preferred GXR to ATX. Patients and caregiver preferences could be useful inputs to the treatment selection decision-making process.https://doi.org/10.36469/9842 |
spellingShingle | Emuella Flood Kavita Gajria Vanja Sikirica Paul Hodgkins M. Haim Erder Frank Lopez Daniel Connor Preferences for Attention-Deficit/Hyperactivity Disorder (ADHD) Non-Stimulant Treatment Characteristics Among Children and Adolescents With ADHD and Their Caregivers Journal of Health Economics and Outcomes Research |
title | Preferences for Attention-Deficit/Hyperactivity Disorder (ADHD) Non-Stimulant Treatment Characteristics Among Children and Adolescents With ADHD and Their Caregivers |
title_full | Preferences for Attention-Deficit/Hyperactivity Disorder (ADHD) Non-Stimulant Treatment Characteristics Among Children and Adolescents With ADHD and Their Caregivers |
title_fullStr | Preferences for Attention-Deficit/Hyperactivity Disorder (ADHD) Non-Stimulant Treatment Characteristics Among Children and Adolescents With ADHD and Their Caregivers |
title_full_unstemmed | Preferences for Attention-Deficit/Hyperactivity Disorder (ADHD) Non-Stimulant Treatment Characteristics Among Children and Adolescents With ADHD and Their Caregivers |
title_short | Preferences for Attention-Deficit/Hyperactivity Disorder (ADHD) Non-Stimulant Treatment Characteristics Among Children and Adolescents With ADHD and Their Caregivers |
title_sort | preferences for attention deficit hyperactivity disorder adhd non stimulant treatment characteristics among children and adolescents with adhd and their caregivers |
url | https://doi.org/10.36469/9842 |
work_keys_str_mv | AT emuellaflood preferencesforattentiondeficithyperactivitydisorderadhdnonstimulanttreatmentcharacteristicsamongchildrenandadolescentswithadhdandtheircaregivers AT kavitagajria preferencesforattentiondeficithyperactivitydisorderadhdnonstimulanttreatmentcharacteristicsamongchildrenandadolescentswithadhdandtheircaregivers AT vanjasikirica preferencesforattentiondeficithyperactivitydisorderadhdnonstimulanttreatmentcharacteristicsamongchildrenandadolescentswithadhdandtheircaregivers AT paulhodgkins preferencesforattentiondeficithyperactivitydisorderadhdnonstimulanttreatmentcharacteristicsamongchildrenandadolescentswithadhdandtheircaregivers AT mhaimerder preferencesforattentiondeficithyperactivitydisorderadhdnonstimulanttreatmentcharacteristicsamongchildrenandadolescentswithadhdandtheircaregivers AT franklopez preferencesforattentiondeficithyperactivitydisorderadhdnonstimulanttreatmentcharacteristicsamongchildrenandadolescentswithadhdandtheircaregivers AT danielconnor preferencesforattentiondeficithyperactivitydisorderadhdnonstimulanttreatmentcharacteristicsamongchildrenandadolescentswithadhdandtheircaregivers |